oa Valvular heart disease: Patient needs and practice guidelines

References

1. Bonow RO, Carabello BA and Chatterjee K et al. ACC/AHA. 2008 focused update incorporated into the ACC/AHA 2006 Guidelines for the Management of Patients with Valvular Heart Disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease). Circulation. 2008; 118::e523–e661.
   [Google الباحث العلمي]
2. Vahanian A, Baumgartner H and Bax J et al. Guidelines on the management of valvular heart disease. Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007; 28::230–268.
   [Google الباحث العلمي]
3. Tricoci P, Allen KM, Kramer JM, Califf RM and Smith SC Jr. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009; 301::831–841.
   [Google الباحث العلمي]
4. Carpetis JR, Steer AC, Mulholland EK and Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005; 5::685–694.
   [Google الباحث العلمي]
5. Carpetis JR. Rheumatic heart disease in developing countries. N Engl J Med. 2007; 357::439–441.
   [Google الباحث العلمي]
6. Lopez AD, Mathers CD, Ezzati M, Jamison DT and Murray CJL . Global Burden of Disease and Risk Factors. Oxford University Press and World Bank, New York. 2006;
   [Google الباحث العلمي]
7. Marijon E, Ou P and Celermajer DS et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007; 357::470–476.
   [Google الباحث العلمي]
8. World Heart Federation. Rheumatic Heart Disease, Africa. Available at: http://www.world-heart-federation.org/what-we-do/applied-research/rheumatic-heart-disease-demonstration-projects/africa/.
9. Supino, PG ,Borer, JS ,Yin, A ,Dillingham, EandMcClymont, W, The epidemiology of valvular heart Diseases: the problem is growing. In: Borer JS and Isom OW (eds): Pathophysiology, Evaluation and Management of Valvular Heart Diseases, Volume II. Adv Cardiol. Basel, Karger, 2004, vol 41, pp 9–15.
10. Mensah GA. The burden of valvular heart disease. Otto CM and Bonow RO(eds), Valvular Heart Disease: A Companion to Braunwald’s Heart Disease. 2009;Saunders/Elsevier, Philadelphia. 1–18.
    [Google الباحث العلمي]
11. Lindroos M, Kupari M, Heikkila J and Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993; 21::1220–1225.
    [Google الباحث العلمي]
12. Singh JP, Evans JC and Levy D et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999; 83::897–902.
    [Google الباحث العلمي]
13. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG and Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006; 368::1005–1011.
    [Google الباحث العلمي]
14. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR and Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001; 103::1759–1764.
    [Google الباحث العلمي]
15. Koelling TM, Aaronson KD, Cody RJ and Bach MD. Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J. 2002; 144::524–529.
    [Google الباحث العلمي]
16. Robbins JD, Maniar PB, Cotts W, Parker MS, Bonow RO and Gheorghiade M. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol. 2003; 91::360–362.
    [Google الباحث العلمي]
17. Brown JM, O’Brien SM, Wu C, Sikora JH, Griffith BP and Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009; 137::82–90.
    [Google الباحث العلمي]
18. Goodney PP, O’Connor GT, Wennberg DE and Birkmeyer JE. Do hospitals with low mortality rates in coronary artery bypass also perform well in valve replacement?. Ann Thorac Surg. 2003; l76::1131–1137.
    [Google الباحث العلمي]
19. Gammie JS, O’Brien SM, Griffith BP, Ferguson TB and Peterson ED. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation. 2007; 115::881–886.
    [Google الباحث العلمي]
20. Gammie JS, Sheng S and Griffith BP et al. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Database. Ann Thorac Surg. 2009; 87::1431–1439.
    [Google الباحث العلمي]
21. Bolling SF, Li S, O’Brien SM, Brennan JM, Prager RL and Gammie JS. Predictors of mitral valve repair: clinical and surgeon factors. Ann Thorac Surg. 2010; 90::1904–1912.
    [Google الباحث العلمي]
22. Schelbert EB, Vaughan-Sarrazin MS, Welke KF and Rosenthal GE. Hospital volume and selection of valve type in older patients undergoing aortic valve replacement surgery in the United States. Circulation. 2005; 111::2178–2182.
    [Google الباحث العلمي]
23. Bouma BJ, van den Brink RBA and van der Meulen JHP et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart. 1999; 82::143–148.
    [Google الباحث العلمي]
24. Iung B, Cachier A and Baron G et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?. Eur Heart J. 2005; 26::2714–2720.
    [Google الباحث العلمي]
25. Pellikka PA, Sarano ME and Nishimura RA et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005; 111::3290–3295.
    [Google الباحث العلمي]
26. Bach DS, Siao D and Girard SE et al. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes. 2009; 2::533–539.
    [Google الباحث العلمي]
27. Mirabel M, Iung B and Baron G et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?. Eur Heart J. 2007; 28::1358–1365.
    [Google الباحث العلمي]
28. Toledano K, Rudski LG, Huynh T, Béïque F, Sampalis J and Morin J. Mitral regurgitation: determinants of referral for cardiac surgery by Canadian cardiologists. Canad J Cardiol. 2007; 23::209–214.
    [Google الباحث العلمي]
29. Bach DS, Awaia M, Gurm HS and Kohnstamm S. Valvular heart disease: failure of guideline adherence for intervention in patients with severe mitral regurgitation. J Am Coll Cardiol. 2009; 54::860–865.
    [Google الباحث العلمي]
30. Tribouilloy CM, Enriquez-Sarano M and Schaff HV et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation. 1999; 99::400–405.
    [Google الباحث العلمي]
31. David TE, Ivanov J, Armstrong S and Rakowski H. Late outcomes of mitral valve repair for floppy valves: implications for asymptomatic patients. J Thorac Cardiovasc Surg. 2003; 125::1143–1152.
    [Google الباحث العلمي]
32. Spertus JA, Bonow RO and Chan P et al. ACC/AHA 2010 methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care update: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circulation. 2010; 122::2091–2106.
    [Google الباحث العلمي]
33. Califf RM, Peterson ED and Gibbons RJ et al. Integrating quality into the cycle of therapeutic development. J Am Coll Cardiol. 2002; 40::1895–1901.
    [Google الباحث العلمي]
34. Bridgewater B, Hooper T and Munsch C et al. Mitral repair best practice: proposed standards. Heart. 2006; 92::939–944.
    [Google الباحث العلمي]